Contact dermatitis: As the name suggests, contact dermatitis occurs from irritant exposure
Scandinavian Journal of Gastroenterology , 44 (6), 712719
When comparing natalizumab and fingolimod, though, it was found that while the former had a 1.9% relapse rate in follow-up, the later was as high as 22.3%
[4] This is the conceptual seed for studying it as an injected agent
Consumer demand for non-invasive, results-oriented treatments continues to fuel investment in new peel formulations
It is generally avoided in pregnancy, in people with certain gastrointestinal conditions, and where a clinician identifies a contraindication during screening